ArticleJournal of neuro-oncology2011

Cediranib enhances control of wild type EGFR and EGFRvIII-expressing gliomas through potentiating temozolomide, but not through radiosensitization: implications for the clinic.

Phyllis R Wachsberger et al.PubMed ↗Publisher ↗

No numbers read from the abstract.